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LETTERS TO THE EDITOR
Concordance of Genetic Changes in Basal Cell Carcinoma and
Associated Clusters of Squamous Cells
To the Editor:
Basal cell carcinomas (BCC) may show areas with morphologically
distinct squamous cells. In individual cases, it may be difficult to
evaluate whether the squamous cell component in BCC represents
squamous differentiation of a BCC precursor cell or an independent
squamous neoplasia. The nevoid BCC syndrome tumor suppressor
gene, patched, has been cloned and localized on chromosome 9q22.3-
q31 (Hahn et al, 1996). Recent studies suggest that alterations of the
patched gene not only occur in BCC that are associated with the basal
nevus cell syndrome, but also in µ50% of sporadic BCC (Takata et al,
1996). Furthermore, 9q22.3-q31 alterations are rarely observed in
squamous neoplasia (Rees, 1994). Therefore, the specificity of genetic
changes in BCC may prove useful to differentiate between different
histologic areas in BCC associated with a squamous cell component.
From the files of our Department, 38 cases of ‘‘atypical BCC with
squamous differentiation’’ were retrieved. From these 38 cases, four
cases were selected showing circumscribed areas of squamous cells that
were located in the deep portions of the tumor and were not associated
with epidermal or follicular epithelium.
From the hematoxylin and eosin stained slides, the following tissue
samples were microdissected and selectively procured under microscope
visualization (Zhuang et al, 1995): (i) areas of BCC, (ii) areas of
squamous cells, and (iii) normal structures, e.g., epidermis, sebaceous
glands, or infiltrates (Fig 1a). From the procured cells, DNA was
extracted and amplified using the markers D9S303, D9S287, IFNA,
D9S171, and TP53 as described previously (Zhuang et al, 1995). The
amplification products were electrophoresed on a 8% polyacrylamid
gel and visualized.
Three of four BCC with areas of squamous cells showed loss of
heterozygosity (LOH) at the BCC locus with either D9S303 or D9S287
(Fig 1b). Whenever LOH was observed in the BCC component with
either D9S303 or D9S287, loss of the same allele was also seen in the
squamous cell component (cases 1, 2, and 4). Whenever heterozygosity
was retained in the BCC component in these cases with either D9S303
or D9S287, it was also retained in the squamous cell component. One
case (case 3) showed no LOH with D9S303 and was noninformative
with D9S287 and these results were found in both the BCC and
the squamous cell component. Therefore, deletions were entirely
concordant in both squamous cells and BCC areas in all cases studied.
Using the markers IFNA, D9S171, and TP53, which frequently show
LOH in squamous cell carcinomas (SCC) (Rees, 1994), no LOH was
detected in either BCC or associated squamous cell components. Three
of four SCC, serving as a control, showed LOH with at least one
marker on 9p and 17p, and all control SCC were negative for markers
corresponding to the BCC locus.
In summary, in each individual tumor, genetic analysis of different
areas showed entirely concordant changes. Furthermore, the genetic
changes were consistent with the BCC genotype, whereas characteristic
genetic changes of squamous neoplasia were not observed in areas of
either BCC or squamous cells. These results suggest that the areas of
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squamous cells represent squamous differentiation of BCC or BCC
precursor cells rather than independent areas of squamous neoplasia.
Based on genetic analysis, these results strongly indicate that BCC
may focally develop into areas of pure squamous morphology. The
results are of particular interest, since BCC have been reported with
areas of malignant squamous cells, so-called basosquamous carcinoma;
however, the existence of basosquamous carcinoma as a separate entity
is controversial (Lever and Schaumburg-Lever, 1990). Using tissue
microdissection in a larger number of controversial cases may eventually
clarify whether morphologic tumor heterogeneity is associated with
Figure 1. (a) Hematoxylin and eosin sections of two areas of BCC with areas
of squamous cells (left, case 2; right, case 4). Original magnification 3200.
Areas of BCC and areas of squamous cells (arrows) were selectively microdissected.
Genetic analysis of the dissected areas showed entirely concordant genetic
changes. (b) LOH analysis of BCC with areas of squamous cells with primers
corresponding to the BCC locus showing concordant genetic changes in areas
of BCC (BC) and squamous cells (SC). N, normal tissue control.
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concordant, progressive, or diverse genetic changes. In tumors in
which the differentiation of SCC and BCC is difficult based on
histologic examination only and is of clinical or investigative import-
ance, microdissection of different tumor components with subsequent
genetic analysis may prove to be a useful diagnostic tool in the
future.
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On the Morphogenesis of a Psoriatic Lesion
To the Editor:
In the December issue of the Journal of Investigative Dermatology,
Iizuka et al (1997) made the assumption that the number of total
viable epidermal cells is parallel to that of the proliferative
compartment in the steady state of cell flow.
This is exact for an established lesion of psoriasis where, effectively,
cell loss by desquamation is compensated by an equivalent cell
production by the germinative compartment but cannot explain the
creation of a psoriatic lesion with its typical morphology (Heenen
and Galand, 1984).
What are the minimal kinetic defects needed to generate a
psoriatic-like morphology?
1 The increased size of the germinative compartment corresponds
to a temporary imbalance between the proportion of germinative
cells that repeat the cycle and those that differentiate and migrate
into the differentiating compartment. An acceleration of cell
production (be it by increasing the growth fraction or by reducing
the cell cycle) is insufficient for explaining the growth of the
germinative compartment. When the psoriatic lesion is clinically
stable, this kinetic perturbation has ceased (Heenen et al, 1987).
2 The increased size of the differentiated compartment is determined
by the value of the ratio between the transit time (or residence
time) in the differentiated compartment and the turnover time of
the germinative compartment. Therefore, the morphology of the
psoriatic lesion (increase in absolute size and decrease in relative
size of the differentiated compartment) reflects the fact that the
acceleration of cell transit is more pronounced than that of cell
production in the germinative compartment, and the fact that this
is accompanied by an increase in germinative compartment size.
In conclusion, two perturbations are needed and suffice to account
for the pathogenesis of clinically stable psoriatic lesions: a temporary
disturbance of the steady state of the germinative layers, resulting
in limited growth of this compartment (this has ceased in developed
lesions), and a permanent decrease in the transit time in the
differentiated compartment.
How can the extension of the germinative cell pool be achieved?
Two alternative explanations (not mutually exclusive) can be
proposed. The germinative compartment in human epidermis is
probably composed of a small fraction of stem cells with unlimited
division potential and a greater proportion of transit amplifying cells
already committed to differentiation and with a limited number of
divisions remaining (Potten and Morris, 1988). Increased size of the
1Heenen M, Heenen PH: Extension of the germinative population in
psoriasis. Cell Tissue Kinet 22:169, 1989 (abstr.)
2Laporte M, Galand P, Fokan D, De Graef CH, Heenen M: Apoptosis
in normal skin, psoriasis and healing psoriasis. J Invest Dermatol
106:865, 1996 (abstr.)
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germinative population can be obtained by an increased number of
cell divisions in the amplifying compartment. This hypothesis is
supported by the observation of involucrin in psoriatic lesions, a
terminal differentiation marker, in cells labeled by [3H]thymidine
(Dover and Watt, 1987), and by mathematical simulations.1
Apoptosis is probably an important regulatory mechanism in
epidermal homeostasis. Another possibility is that physiologic apoptosis
in the germinative compartment is temporarily decreased.2 This is
consistent with the observation that psoriatic keratinocytes overexpress
Bcl-xL, a protein that prevents apoptosis (Wrone-Smith et al, 1995).
Michel Heenen
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Reply:
We are grateful for Dr. Heenen’s interest in our paper. As he
correctly points out, we assumed that the total number of viable
epidermal cells paralleled that of the proliferative compartment in a
steady state of cell flow (Iizuka et al, 1997). It should be noted,
however, that we did not intend to explain the creation or
resolution of the psoriatic lesion, which is apparently Dr. Heenen’s
point. Rather, we intended to explain psoriatic architecture in a
steady state of cell flow, which is determined by our assumption.
We would like to point out that this simple assumption is directly
related to in vivo psoriatic morphology and its typically angulated
rete-papilla pattern.
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